News Legal Alert life sciences Publications
Tuesday May 31st, 2022
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
RESTRICTIONS ON TRADE Adding more products to the anti-export list (the requirement to report export to the Chief Pharmaceutical Inspectorate (GIF) 30 days…
The hemp market includes food products, cosmetic products, but also pharmaceutical raw materials or products for animals. What should an…
We are pleased to inform that veterinary clinic “Wróblewscy” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
“SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”. One of the…
We are pleased to inform that veterinary clinic “Animal” located in Łódź has joined AniCura, a family of leading veterinary…
We are pleased to inform that “The Life Sciences Law Review – Edition 6” has been published. Polish chapter authored…
General information CBD (cannabidiol) has been steadily gaining popularity for some years now, and the global CBD market is expected…
According to the EU Directive, Member States shall ensure that medicinal products which are Over-The-Counter Drug (OTC) are offered for…
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…
We are pleased to announce that our IP team won a Gold Laurel in the ranking of the IAM Patent…
The Intellectual Property law team of Sołtysiński Kawecki & Szlęzak has been awarded a Gold Laurel in Intellectual Asset Management…
EU regulations on medical devices (MDR[1]) and in vitro diagnostic medical devices (IVDR[2]) have been applied for several years now…
We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 13…
On March 21, 2023, the long-awaited act on clinical trials of medicinal products for human use was signed by the…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…